Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: synchro who wrote (7546)	4/29/1999 12:59:00 AM
From: BigKNY3	Read Replies (1) \| Respond to of 9523

Cramer is your typical analyst who will actively support his current position with facts and fiction and with no accountability. Here is an example of problems with Cramer's Big Pharma current position: Cramer: "There are lots of secular reasons why the drugs make sense to sell. The federal government is sick of paying high prices for drugs." BigKNY3 Opinion: There will not be any price controls for pharmaceuticals. No Medicare Rx legislation will even be considered until after the 2000 Presidential elections. Cramer: "The competition among the drug companies has never been as intense (for the longest time, only Merck (MRK:NYSE) and Pfizer (PFE:NYSE) seemed like class acts, but now everybody seems like one, even the Upjohns (PNU:NYSE) and the Warner-Lamberts (WLA:NYSE), which means there is too much competition)." BigKNY3 Opinion: MRK and PFE are still way ahead of the PNUs and WLAs in terms of class. Cramer "And if you can buy drugs on the Net, soon the buying power will go to the Net buyers (drugstore.com, etc.) vs. the cozy drug oligopoly. Don't underestimate the power of Bezos & Co. to dictate pricing on the chronically prescribed drugs. It will happen." BigKNY3 Opinion: Cramer has too much .com on the brain. Internet pharmacies will have no impact on the future of Pharma pricing. I doubt these ventures will even survive.